Live Cell Encapsulation - Global Strategic Business Report

Global Live Cell Encapsulation Market to Reach $388.1 Million by 2030

The global market for Live Cell Encapsulation estimated at US$291.6 Million in the year 2022, is projected to reach a revised size of US$388.1 Million by 2030, growing at a CAGR of 3.6% over the analysis period 2022-2030. Alginate, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$117.8 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chitosan segment is readjusted to a revised 3.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $79.5 Million, While China is Forecast to Grow at 6.4% CAGR

The Live Cell Encapsulation market in the U.S. is estimated at US$79.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$80.7 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.7% and 2.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Select Competitors (Total 43 Featured) -

• Altucell, Inc.
• Beta-O2 Technologies Ltd
• Biotime, Inc.
• Blacktrace Group
• Büchi Labortechnik AG
• Defymed
• Evonik Industries
• Gloriana Therapeutics
• Kadimastem
• Living Cell Technologies
• Neurotech Holdings, LLC.
• Pharmacyte Biotech, Inc.
• Sernova Corporation
• Sigilon Therapeutics
• Viacyte, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year